drugset / Trial / NCT02952716
Treatment of Human Cord Blood Mononuclear Cell for Delayed Encephalopathy After Carbon Monoxide Poisoning
RandomizedParallel-groupDouble-blindTreatment
Summary
The effects and safety of Human cord blood mononuclear cell for delayed encephalopathy after carbon monoxide poisoning
Timeline
- Start
- 2016-10
- Primary completion
- 2018-10
- Completion
- 2019-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Human cord blood mononuclear cell | Cell therapy | — | Other |